Innotubilin 20mg Injection

About

Innotubilin 20mg Injection is a targeted parenteral medication, delivering 20mg of its active cytotoxic compound, typically via intravenous infusion. This lower-dose formulation is designed to provide a precise and effective anti-cancer action, often used in specific chemotherapy regimens or for maintenance therapy where a less aggressive but sustained effect is desired. The active ingredient works by selectively interfering with the growth and division of rapidly proliferating cancer cells, often by disrupting microtubule dynamics or DNA synthesis. By targeting these fundamental cellular processes, Innotubilin 20mg helps to inhibit tumor progression and induce cell death in malignant tissues. The injectable route ensures optimal bioavailability and consistent drug levels, crucial for achieving therapeutic efficacy. This dosage is carefully chosen to balance anti-tumor activity with a manageable side effect profile, making it suitable for various oncological indications.

Uses

• Treatment of specific types of solid tumors.
• Management of certain hematological cancers.
• Maintenance therapy in remission phases.
• Part of combination chemotherapy regimens.

Directions For Use

Administer intravenously under the guidance of an oncologist. Dosage, infusion rate, and treatment schedule are tailored to the patient's specific cancer and tolerance.

Benefits

• Effective in inhibiting cancer cell growth.
• Contributes to tumor regression.
• Can prolong progression-free survival.
• Well-suited for combination therapies.
• Offers a systemic approach to cancer treatment.
• Potentially lower toxicity profile compared to higher doses.

Side Effects

• Nausea and occasional vomiting.
• Fatigue.
• Mild hair thinning.
• Myelosuppression (reduced blood counts).
• Peripheral neuropathy (tingling, numbness).
• Diarrhea.
• Mucositis (mouth sores).
• Injection site reactions.
• Allergic reactions (rare).
• Muscle aches.
• Elevated liver enzymes.
• Kidney function changes.

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may increase the risk of liver toxicity and gastrointestinal side effects.
• Pregnancy - Contraindicated during pregnancy due to potential teratogenic effects; strict contraception is required for both male and female patients.
• Breastfeeding - Not recommended; discontinue breastfeeding due to potential harm to the infant from excretion in breast milk.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary, and liver function should be closely monitored.
• Kidney - Exercise caution in patients with renal dysfunction; dose modification may be required, and kidney function should be regularly assessed.
• Lung - Use with caution in patients with pre-existing lung conditions, as some cytotoxic agents can cause pulmonary toxicity.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.